Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
about
Antifibrinolytic drugs for acute traumatic injuryHaemostatic drugs for traumatic brain injuryAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionAntifibrinolytic therapy to reduce hemoptysis from any causePlatelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusionCell salvage for minimising perioperative allogeneic blood transfusionHaemostatic drugs for traumatic brain injuryDesmopressin for minimising perioperative allogeneic blood transfusionPlatelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusionFibrin sealant use for minimising peri-operative allogeneic blood transfusionThe Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A ReviewEpsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trialsCRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social MediaEfficacy and safety of using antifibrinolytic agents in spine surgery: a meta-analysisAntifibrinolytic therapy to reduce haemoptysis from any cause.Tranexamic acid in obstetrics: Encouraging data in anemic parturients.Anti-fibrinolytic agents in post partum haemorrhage: a systematic review.A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery.Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation.The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.Efficacy of tranexamic acid in reducing blood loss in posterior lumbar spine surgery for degenerative spinal stenosis with instability: a retrospective case control study.Pre-operative autologous donation for minimising perioperative allogeneic blood transfusionSafety and efficacy of caproamin fides and tranexamic Acid versus placebo in patients undergoing coronary artery revascularizationPharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial.Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative periodRecommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative periodTopical tranexamic Acid does not affect electrophysiologic or neurovascular sciatic nerve markers in an animal model.Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study).Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.Impact of aprotinin and renal function on mortality: a retrospective single center analysis.High-dose tranexamic acid reduces blood loss in postpartum haemorrhage.Comparison of treatment effects between animal experiments and clinical trials: systematic review.Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.Anesthetic Considerations in Hepatectomies under Hepatic Vascular ControlActive Bleeding after Cardiac Surgery: A Prospective Observational Multicenter StudyA Comparison of Two Different Dosing Protocols for Tranexamic Acid in Posterior Spinal Fusion for Spinal Deformity: A Prospective, Randomized Trial.
P2860
Q24188000-57C55B16-AFF5-4CFA-8367-D603B6AB9E6AQ24188122-159265D2-DFD2-472A-AC25-2348CD565227Q24235627-07B11302-EA3D-4605-81DE-3354C573660BQ24235701-4B828718-4C01-4D54-94EA-458D5E8CE2B3Q24235886-E39C0F81-B22F-42DD-87D4-B5550573B315Q24235950-28C9D05A-44C8-4D63-B055-A6F1ABF34E56Q24240304-CBE3527A-6689-4EAF-95EC-E4187981A5CDQ24247402-61EF7339-2594-4178-96C1-6B0F7C35D906Q24250237-58CFAC9F-98CA-4126-A183-D65B834592B1Q24250264-9379BE4E-7CEB-4342-B460-70CEA59A730BQ26769936-DED9F83A-99B2-4BDA-BB2B-D9E0F828F6E7Q26785349-9677AADC-228C-45F4-87BD-A08D42FC93D6Q26785966-FA8AD48C-F83C-49E2-A5F0-4F43D2FE23B6Q28535382-9E7D5C4C-4914-45AD-B19B-3FFA2F79812FQ30241963-18ACD553-D7CC-4718-AFC6-751D7A675480Q30717607-B5599F68-CF60-4FFA-9FCE-8B3641C6D945Q33482473-06516570-F91B-4042-A0DD-57625E76C164Q33549947-3F334EE8-C398-419B-A5FF-A2AB38356376Q33705524-88C0B12C-4023-47DC-9622-363656702BE8Q33828581-2534116C-66B1-44AB-944C-1275D475B074Q34064761-F8338E45-C6FA-4BBF-91C5-15410E8C49FDQ34065040-E6151918-1AB2-4AB0-A763-DCC4EB17A58EQ34226667-CC1584DD-07CC-4DA0-853F-A4D125F8E115Q34333498-60616D1F-11AA-4474-9984-986107679BB0Q34422906-D90FBA27-FF7B-432E-867F-E72619C0E148Q34459644-82361812-A8B3-4514-AAC3-6CF1072EB630Q34492729-F8257C9D-97C2-47EF-8DB9-8C8FECAFE812Q34988663-B9ECE0F6-84C0-452E-875D-2CD73829F0D6Q35050330-F15E03EF-D7FA-47F7-A250-5F634BF4E437Q35079577-7AF37B73-824D-4761-B6FA-810A54742068Q35083166-221CE507-AD43-4FFE-9713-501627AC092CQ35106170-A3D97D08-F8E8-4E12-AB78-47F5A073A7FDQ35227600-12081BAD-62CE-434F-AE3B-96E2764C24A7Q35559634-A61AA2DC-9E0F-4852-98FA-A7C1BF0368E1Q35610097-C0DB019E-70B9-4323-95F5-022AF73F0156Q35662691-FD17A3DB-B504-4862-813D-6866FE2F3C17Q35683857-950C52A5-2052-41BE-B5B6-892D2CA3B186Q36011525-105CB853-8CB6-47EC-83B3-E2B700DC411CQ36121480-7AC9A6A5-248A-4BEF-8A05-82B4BC720D60Q36455146-FCCD3DCA-CA6C-4990-85CC-F32F601C01E9
P2860
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@ast
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
type
label
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@ast
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
prefLabel
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@ast
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
P2093
P2860
P3181
P1476
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
P2093
Andreas Laupacis
Annette J Moxey
Barrie J Stokes
Brian McClelland
Dianne O'Connell
Paul A Carless
P2860
P3181
P356
10.1002/14651858.CD001886.PUB2
P577
2007-10-17T00:00:00Z